Human Genome Sciences

Human Genome Sciences is a biopharmaceutical company that specializes in the development of innovative pharmaceutical products through genomic research. The company is focused on advancing its pipeline of therapies, with three products currently in late-stage clinical development. By leveraging genomic insights, Human Genome Sciences aims to address unmet medical needs and improve patient outcomes in various therapeutic areas.

J. Craig Venter

Founder

1 past transactions

CoGenesys

Series A in 2006
CoGenesys is a biopharmaceutical company dedicated to the development of peptide- and protein-based medicines. The company focuses on creating therapeutics for a range of diseases, including cancer, cardiovascular, metabolic, infectious, autoimmune, and central nervous system disorders. CoGenesys conducts clinical trials to demonstrate the safety and efficacy of its bio-therapeutics, and subsequently seeks to license or partner its compounds to secure funding for continued development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.